These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2529742)

  • 1. Inhibition of autoimmune disease and the generation of suppressor cells by spirogermanium: a biological profile similar to total lymphoid irradiation.
    Badger AM; Mirabelli CK; Swift BA; DiMartino MJ
    Agents Actions; 1989 Jun; 27(3-4):335-7. PubMed ID: 2529742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory activity and non-specific suppressor cell generation by spirogermanium in murine and rat models of cell-mediated immunity.
    Badger AM; DiMartino MJ; Swift BA; Mirabelli CK
    Immunopharmacology; 1988; 16(1):33-43. PubMed ID: 2971635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarthritic and immunoregulatory activity of spirogermanium.
    DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
    J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.
    Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N
    Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.
    Badger AM; Mirabelli CK; DiMartino M
    Immunopharmacology; 1985 Dec; 10(3):201-7. PubMed ID: 2939040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cell induction by the anticancer drug spirogermanium.
    Badger AM; DiMartino MJ; Schmitt TC; Swift BA; Mirabelli CK
    Int J Immunopharmacol; 1987; 9(5):621-30. PubMed ID: 2957334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.
    Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK
    J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.
    Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N
    J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603.
    Ohta Y; Fukuda S; Makino H
    Immunopharmacology; 1997 Oct; 37(2-3):167-74. PubMed ID: 9403335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity.
    Badger AM; Swift BA
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study on the suppression of experimental autoimmune encephalomyelitis in the Lewis rat with spirogermanium.
    Sacks HJ; Braunstein V; Brosnan CF
    J Neuropathol Exp Neurol; 1987 May; 46(3):250-61. PubMed ID: 3494106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
    Matsumoto Y; Fujiwara M
    Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis.
    McDonald AH; Swanborg RH
    J Immunol; 1988 Feb; 140(4):1132-8. PubMed ID: 2963860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.
    Holda JH; Welch AM; Swanborg RH
    Eur J Immunol; 1980 Aug; 10(8):657-9. PubMed ID: 6967418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat.
    Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R
    Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183
    [No Abstract]   [Full Text] [Related]  

  • 16. CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis.
    Karpus WJ; Swanborg RH
    J Immunol; 1989 Dec; 143(11):3492-7. PubMed ID: 2573635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
    High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
    J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: inhibition by spirogermanium hydrochloride.
    Tanowitz HB; Brennessel DJ; Baum SG; Salgo MP; Braunstein V; Wittner M
    Exp Parasitol; 1987 Aug; 64(1):57-63. PubMed ID: 3301388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the immune response by rapamycin, a new antifungal antibiotic.
    Martel RR; Klicius J; Galet S
    Can J Physiol Pharmacol; 1977 Feb; 55(1):48-51. PubMed ID: 843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.